
Kishor Mayekar
Examiner (ID: 18425, Phone: (571)272-1339 , Office: P/1759 )
| Most Active Art Unit | 1795 |
| Art Unit(s) | 1759, 1102, 1741, 1754, 1795, 2741, 1753 |
| Total Applications | 2436 |
| Issued Applications | 1650 |
| Pending Applications | 176 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3787326
[patent_doc_number] => 05736526
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-07
[patent_title] => 'Mixtures of DDI and D4T with hydroxycarbamide for inhibiting retroviral replication'
[patent_app_type] => 1
[patent_app_number] => 8/577322
[patent_app_country] => US
[patent_app_date] => 1995-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6337
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/736/05736526.pdf
[firstpage_image] =>[orig_patent_app_number] => 577322
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/577322 | Mixtures of DDI and D4T with hydroxycarbamide for inhibiting retroviral replication | Dec 21, 1995 | Issued |
Array
(
[id] => 3933744
[patent_doc_number] => 05929046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-27
[patent_title] => 'Pyrimidine and purine derivatives and their use in treating tumour cells'
[patent_app_type] => 1
[patent_app_number] => 8/572966
[patent_app_country] => US
[patent_app_date] => 1995-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9069
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/929/05929046.pdf
[firstpage_image] =>[orig_patent_app_number] => 572966
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/572966 | Pyrimidine and purine derivatives and their use in treating tumour cells | Dec 14, 1995 | Issued |
Array
(
[id] => 3828733
[patent_doc_number] => 05783688
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-21
[patent_title] => 'Purification of 3\'-FDDU and resultant compositions'
[patent_app_type] => 1
[patent_app_number] => 8/545841
[patent_app_country] => US
[patent_app_date] => 1995-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2266
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/783/05783688.pdf
[firstpage_image] =>[orig_patent_app_number] => 545841
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/545841 | Purification of 3'-FDDU and resultant compositions | Dec 11, 1995 | Issued |
| 08/565237 | NOVEL 2'-HALOMETHYLIDENE, 2'-ETHENYLIDENE AND 2'-ETHYNYL CYTIDINE, URIDINE AND GUANOSINE DERIVATIVES | Nov 29, 1995 | Abandoned |
Array
(
[id] => 4239582
[patent_doc_number] => 06080730
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'Rinse solution for organs and tissues'
[patent_app_type] => 1
[patent_app_number] => 8/563893
[patent_app_country] => US
[patent_app_date] => 1995-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3281
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080730.pdf
[firstpage_image] =>[orig_patent_app_number] => 563893
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/563893 | Rinse solution for organs and tissues | Nov 21, 1995 | Issued |
Array
(
[id] => 3832038
[patent_doc_number] => 05739313
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Radionuclide labeling of vitamin B.sub.12 and coenzymes thereof'
[patent_app_type] => 1
[patent_app_number] => 8/557955
[patent_app_country] => US
[patent_app_date] => 1995-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7213
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739313.pdf
[firstpage_image] =>[orig_patent_app_number] => 557955
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/557955 | Radionuclide labeling of vitamin B.sub.12 and coenzymes thereof | Nov 12, 1995 | Issued |
Array
(
[id] => 4298227
[patent_doc_number] => 06184369
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-06
[patent_title] => 'Anti-viral guanosine-rich oligonucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/535168
[patent_app_country] => US
[patent_app_date] => 1995-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 23
[patent_no_of_words] => 13295
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/184/06184369.pdf
[firstpage_image] =>[orig_patent_app_number] => 535168
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/535168 | Anti-viral guanosine-rich oligonucleotides | Oct 22, 1995 | Issued |
Array
(
[id] => 4022677
[patent_doc_number] => 05925624
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => '2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation'
[patent_app_type] => 1
[patent_app_number] => 8/446727
[patent_app_country] => US
[patent_app_date] => 1995-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43094
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925624.pdf
[firstpage_image] =>[orig_patent_app_number] => 446727
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446727 | 2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation | Sep 17, 1995 | Issued |
Array
(
[id] => 3687914
[patent_doc_number] => 05696097
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-09
[patent_title] => 'Antineoplastic 5\'-diacylglycerylphosphatidyl-2-deoxy-2\'-methylenylcytidines and method of making'
[patent_app_type] => 1
[patent_app_number] => 8/525606
[patent_app_country] => US
[patent_app_date] => 1995-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6179
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/696/05696097.pdf
[firstpage_image] =>[orig_patent_app_number] => 525606
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/525606 | Antineoplastic 5'-diacylglycerylphosphatidyl-2-deoxy-2'-methylenylcytidines and method of making | Sep 14, 1995 | Issued |
Array
(
[id] => 3622597
[patent_doc_number] => 05614622
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-25
[patent_title] => '5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses'
[patent_app_type] => 1
[patent_app_number] => 8/518921
[patent_app_country] => US
[patent_app_date] => 1995-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3281
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/614/05614622.pdf
[firstpage_image] =>[orig_patent_app_number] => 518921
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/518921 | 5-pentenoyl moiety as a nucleoside-amino protecting group, 4-pentenoyl-protected nucleotide synthons, and related oligonucleotide syntheses | Aug 23, 1995 | Issued |
Array
(
[id] => 3880192
[patent_doc_number] => 05804684
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-08
[patent_title] => 'Method for isolating nucleic acids'
[patent_app_type] => 1
[patent_app_number] => 8/519039
[patent_app_country] => US
[patent_app_date] => 1995-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9246
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/804/05804684.pdf
[firstpage_image] =>[orig_patent_app_number] => 519039
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/519039 | Method for isolating nucleic acids | Aug 23, 1995 | Issued |
Array
(
[id] => 3876890
[patent_doc_number] => 05747473
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-05
[patent_title] => 'L-nucleoside analogues and pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/516551
[patent_app_country] => US
[patent_app_date] => 1995-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17194
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/747/05747473.pdf
[firstpage_image] =>[orig_patent_app_number] => 516551
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/516551 | L-nucleoside analogues and pharmaceutical compositions | Aug 17, 1995 | Issued |
Array
(
[id] => 3757991
[patent_doc_number] => 05721219
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-24
[patent_title] => 'N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation'
[patent_app_type] => 1
[patent_app_number] => 8/512979
[patent_app_country] => US
[patent_app_date] => 1995-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6394
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/721/05721219.pdf
[firstpage_image] =>[orig_patent_app_number] => 512979
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/512979 | N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation | Aug 8, 1995 | Issued |
Array
(
[id] => 3664184
[patent_doc_number] => 05625056
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Derivatives of cyclic guanosine-3\',5\'-monophosphorothioate'
[patent_app_type] => 1
[patent_app_number] => 8/511664
[patent_app_country] => US
[patent_app_date] => 1995-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5065
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/625/05625056.pdf
[firstpage_image] =>[orig_patent_app_number] => 511664
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/511664 | Derivatives of cyclic guanosine-3',5'-monophosphorothioate | Aug 6, 1995 | Issued |
Array
(
[id] => 3701131
[patent_doc_number] => 05646127
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-08
[patent_title] => 'Treatment of cardiac ischemia by administration of a fraction of partially depolymerized DNA'
[patent_app_type] => 1
[patent_app_number] => 8/510622
[patent_app_country] => US
[patent_app_date] => 1995-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/646/05646127.pdf
[firstpage_image] =>[orig_patent_app_number] => 510622
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/510622 | Treatment of cardiac ischemia by administration of a fraction of partially depolymerized DNA | Aug 2, 1995 | Issued |
Array
(
[id] => 3841784
[patent_doc_number] => 05744595
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-28
[patent_title] => 'Propargyl modified nucleosides and nucleotides'
[patent_app_type] => 1
[patent_app_number] => 8/520968
[patent_app_country] => US
[patent_app_date] => 1995-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 6730
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/744/05744595.pdf
[firstpage_image] =>[orig_patent_app_number] => 520968
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/520968 | Propargyl modified nucleosides and nucleotides | Jul 24, 1995 | Issued |
Array
(
[id] => 3648040
[patent_doc_number] => 05683989
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-04
[patent_title] => 'Treatment of ischemias by administration of 2,N.sup.6 -substituted adenosines'
[patent_app_type] => 1
[patent_app_number] => 8/504811
[patent_app_country] => US
[patent_app_date] => 1995-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14410
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/683/05683989.pdf
[firstpage_image] =>[orig_patent_app_number] => 504811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/504811 | Treatment of ischemias by administration of 2,N.sup.6 -substituted adenosines | Jul 19, 1995 | Issued |
Array
(
[id] => 4064419
[patent_doc_number] => 05866563
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-02
[patent_title] => 'Vanadium compositions'
[patent_app_type] => 1
[patent_app_number] => 8/480017
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10332
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/866/05866563.pdf
[firstpage_image] =>[orig_patent_app_number] => 480017
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/480017 | Vanadium compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 3646611
[patent_doc_number] => 05637573
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-06-10
[patent_title] => 'Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions'
[patent_app_type] => 1
[patent_app_number] => 8/483497
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6352
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/637/05637573.pdf
[firstpage_image] =>[orig_patent_app_number] => 483497
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483497 | Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 3726427
[patent_doc_number] => 05700786
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-23
[patent_title] => 'Analogues of adenosine 5\'diphosphate and pharmaceutical compositions thereof'
[patent_app_type] => 1
[patent_app_number] => 8/479653
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10896
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/700/05700786.pdf
[firstpage_image] =>[orig_patent_app_number] => 479653
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479653 | Analogues of adenosine 5'diphosphate and pharmaceutical compositions thereof | Jun 6, 1995 | Issued |